Arcutis Biotherapeutics Inc. (ARQT): Price and Financial Metrics

Arcutis Biotherapeutics Inc. (ARQT): $8.74

0.20 (-2.24%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add ARQT to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#126 of 359

in industry

ARQT Price/Volume Stats

Current price $8.74 52-week high $15.21
Prev. close $8.94 52-week low $1.76
Day low $8.72 Volume 1,595,700
Day high $9.30 Avg. volume 4,691,968
50-day MA $10.03 Dividend yield N/A
200-day MA $6.51 Market Cap 846.15M

ARQT Stock Price Chart Interactive Chart >


Arcutis Biotherapeutics Inc. (ARQT) Company Bio


Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its piepline consists of topical treatments for plaque psoriasis, atopic dermatitis, eczema, vitiligo, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne on June 1, 2016 and is headquartered in Westlake Village, CA.


ARQT Latest News Stream


Event/Time News Detail
Loading, please wait...

ARQT Latest Social Stream


Loading social stream, please wait...

View Full ARQT Social Stream

Latest ARQT News From Around the Web

Below are the latest news stories about ARCUTIS BIOTHERAPEUTICS INC that investors may wish to consider to help them evaluate ARQT as an investment opportunity.

The Zacks Analyst Blog Highlights Allogene Therapeutics, Arcutis Biotherapeutics and C4 Therapeutics

Allogene Therapeutics, Arcutis Biotherapeutics and C4 Therapeutics are part of the Zacks top Analyst Blog.

Yahoo | December 28, 2023

3 Under-$10 Drug Stocks Wall Street Analysts Recommend Buying

We present three small biotech stocks, which most analysts on Wall Street are optimistic about. These companies have upside potential for 2024 following signals of a stabilizing market.

Yahoo | December 27, 2023

11 High Growth Micro-Cap Stocks to Buy

In this article, we discuss 11 high-growth micro-cap stocks to buy. To skip the detailed analysis and past performance of micro-cap stocks, go directly to the 5 High Growth Micro-cap Stocks to Buy. Shares of small companies with market capitalization usually between $50 to $300 million are considered micro-cap stocks. The risk in these investments […]

Yahoo | December 24, 2023

Arcutis (ARQT) Up on FDA Nod for Zoryve in Seborrheic Dermatitis

The FDA approves Arcutis' (ARQT) NDA for Zoryve topical foam 0.3% for treating seborrheic dermatitis in individuals nine years of age and above.

Yahoo | December 19, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

It's time to start the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Monday morning!

William White on InvestorPlace | December 18, 2023

Read More 'ARQT' Stories Here

ARQT Price Returns

1-mo -9.05%
3-mo 91.67%
6-mo 268.78%
1-year -34.19%
3-year -69.83%
5-year N/A
YTD 170.59%
2023 -78.18%
2022 -28.64%
2021 -26.27%
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!